Abstract LB-161: A phase I safety study of NPC-1C, a novel, therapeutic antibody to treat pancreas and colorectal cancers.

Published

Conference Paper

Full Text

Duke Authors

Cited Authors

  • Patel, SP; Morse, MA; Diaz, LA; Azad, NS; Haley, S; Arlen, PM

Published Date

  • April 15, 2013

Published In

  • Clinical Trials

Published By

Digital Object Identifier (DOI)

  • 10.1158/1538-7445.am2013-lb-161

Conference Name

  • Proceedings: AACR 104th Annual Meeting 2013; Apr 6-10, 2013; Washington, DC